Scoping review exploring advancements in topical agent therapies for erectile dysfunction
Topical agents via various mechanisms are effective and well-tolerated treatments for ED. A fast-acting drug that significantly reduces side effects as compared with other options has been discovered. However, its efficacy relative to current first-line therapies remains unclear. Topical agents present a viable therapeutic alternative for individuals who are unable or unwilling to take oral phosphodiesterase 5 inhibitors.
Authors
- Eun‐Jung Yang (ORCID: https://orcid.org/0000-0002-0105-433X)
- Yun-Jung Yang (ORCID: https://orcid.org/0000-0002-3006-1897)
- Se Young Choi (ORCID: https://orcid.org/0000-0002-4615-0966)
Institutions
- Yonsei University (KR)
- Catholic Kwandong University International St. Mary's Hospital (KR)
- Chung-Ang University Hospital (KR)
- Catholic Kwandong University (KR)
Publication Details
- Journal
- Sexual Medicine Reviews
- Published
- 2024-08-11
- DOI
- https://doi.org/10.1093/sxmrev/qeae056
- Citations
- 1
- Primary Topic
- Sexual function and dysfunction studies
- Type
- article
- Field-Weighted Citation Impact
- 0.39
Funders
- National Research Foundation of Korea
- Ministry of Science and ICT, South Korea